Related Experiment Video
Updated: Apr 6, 2026

12:06
Isolation of CD133+ Liver Stem Cells for Clonal Expansion
Published on: October 10, 2011
22.9K
Recent insights into hepatic cancer stem cells
Beatrice Anfuso1, Claudio Tiribelli1,2, Caecilia H C Sukowati3,4
1Fondazione Italiana Fegato, AREA Science Park Basovizza, 34149, Trieste, Italy.
Hepatology International
|July 24, 2015
Summary
Hepatocellular carcinoma (HCC) development involves cancer stem cells (CSCs). Dysregulated pathways and microRNAs activate CSCs, contributing to drug resistance and highlighting CSCs as a therapeutic target in HCC.
Area of Science:
- Hepatobiliary diseases
- Cancer stem cell biology
- Molecular oncology
Background:
- Hepatocellular carcinoma (HCC) development is linked to cancer stem cells (CSCs).
- HCC exhibits significant heterogeneity, leading to diverse CSC profiles.
- Dysregulation of molecular signaling pathways is implicated in CSC activation.
Purpose of the Study:
- To review the latest evidence on CSCs in HCC.
- To explore the role of developmental and oncogenic pathways in HCC CSCs.
- To discuss CSC-related microRNAs and drug resistance in HCC.
Main Methods:
- Literature review of recent studies on CSCs in HCC.
- Analysis of molecular signaling pathways associated with HCC CSCs.
- Examination of microRNA involvement and drug resistance mechanisms.
Main Results:
- CSCs are present in HCC and contribute to its development.
- Aberrant signaling pathways (developmental and oncogenic) are crucial for CSC activation.
- MicroRNAs and drug resistance are significant factors in CSC-mediated HCC progression.
Conclusions:
- CSCs play a critical role in hepatocellular carcinoma.
- Understanding CSC pathways, microRNAs, and drug resistance is key.
- Targeting CSCs offers a promising avenue for novel HCC therapies.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance
2.3K
2.3K
Multipotency of Hematopoietic Stem Cells
4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
4.9K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.9K

